Robert G Finizio insider trades
Open-market stock purchases and sales by Robert G Finizio, Director at ZyVersa Therapeutics, Inc, from SEC Form 4 filings since Feb 27, 2012.
Track record: 57% of 7 scored buys are up 5% or more since purchase, averaging +12%.
Recent trades
No open-market trades in the last 12 months.